Industries > Pharma > Topical Drug Delivery Market Report 2020-2030

Topical Drug Delivery Market Report 2020-2030

Forecasts by Product (Semi-solid Formulations (Creams, Ointments, Lotions, Gels, Pastes)), (Liquid Formulations (Suspensions, Solutions)), Solid Formulations (Powders, Suppositories)), and (Transdermal Products (Transdermal Patches, Transdermal Semi-solids), and by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) PLUS Analysis of Leading Topical Drug Delivery Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 22 October 2020
PAGES: 652
PRODUCT CODE: PHA0811
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0811 Categories: , Tag:

Side Effects of topical drugs due to prolonged application still remains a key restraint in the development of the market. How can drug delivery companies get around this problem? Find out today.

Owing to the COVID-19 pandemic, the supply chain and demand of topical drug delivery has been affected in 2020. But it is not just COVID-19 that affects the future of topical drug delivery. This unique senior report tells you what direction the market will take – and it tells you today.

Discover how to stay ahead
Our 600+ page report provides 600+ tables, charts, and graphs.

By reading this report you will discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market, regional and country specific level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Topical drug delivery Market. See how you can exploit these opportunities.

UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

To access the data contained in this document please email contactus@visiongain.com

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.

Which Factors are Fueling Topical drug delivery Industry Growth?
• High Prevalence of Skin Diseases
• High Prevalence of Eye Diseases
• High Incidence of Burn Injuries
• Increasing Prevalence of Diabetes

Which Factors are Restraining Growth?
• Preference for Alternative Modes of Drug Delivery
• Technical Barriers Related to Skin Irritation & Permeability
• Side Effects of Topical Drugs Due to Prolonged Application

How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. The report from Visiongain gives you key potential revenues up to 2030, evaluates critical development information, trends, opportunities and business outlooks.

Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.

Report Scope
Global Topical Drug Delivery Market 2020-2030 is segmented on the basis of Product, Route of Administration, End User and Geography.

• Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Product:
– Semi-Solid Formulations
o Creams
o Ointments
o Lotions
o Gels
o Pastes
– Liquid Formulations
o Suspensions
o Solutions
– Solid Formulations
o Powders
o Suppositories
– Transdermal Products
o Transdermal Patches
o Transdermal Semi-solids

• Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Route of Administration:
– Dermal Drug Delivery
– Ophthalmic Drug Delivery
– Rectal Drug Delivery
– Vaginal Drug Delivery
– Nasal Drug Delivery

• Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by End-User:
– Home Care Settings
– Hospitals and Clinics
– Burn Centres
– Other Facilities

CTA

• Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Region:
– North America
• U.S.
• Canada
– Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
– Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of APAC
– LAMEA
• Brazil
• Mexico
• Rest of LAMEA

Topical Drug Delivery Market Report 2020-2030

Need industry data? Please contact us today.

• Our study discusses the selected leading companies that are the major players in the Topical drug delivery industry:
– GlaxoSmithKline
– Johnson & Johnson
– Bausch Health Companies
– Merck & Co.
– LEO Pharma
– Hisamitsu Pharmaceutical
– Novartis AG
– Glenmark Pharmaceuticals
– Cipla
– Mylan AV

How the Topical drug delivery Market report helps you
In summary, our 600+ page report provides you with the following knowledge:
– What is the current size of the overall global topical drug delivery market? How much will this market be worth from 2020 to 2030?
– What are the main drivers and restraints that will shape the overall topical drug delivery market over the next ten years?
– What are the main segments within the overall topical drug delivery market? How much will each of these segments be worth for the period 2020 to 2030? How will the composition of the market change during that time, and why?
– What factors will affect that industry and market over the next ten years?
– Which are the leading companies and what are their activities, results, developments, and prospects?
– What are the main trends that will affect the world topical drug delivery market between 2020 and 2030?
– What are the main strengths, weaknesses, opportunities, and threats for the market?
– How will the global topical drug delivery market evolve over the forecasted period, 2020 to 2030?
– Revenue forecasts to 2030 for 4 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, Australia, and India. The report also highlights growth potential in Latin America as well as Middle East & Africa.
– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Topical drug delivery market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Topical drug delivery Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Topical Drug Delivery Market Report 2020-2030: Forecasts by Product (Semi-solid Formulations (Creams, Ointments, Lotions, Gels, Pastes)), (Liquid Formulations (Suspensions, Solutions)), Solid Formulations (Powders, Suppositories)), and (Transdermal Products (Transdermal Patches, Transdermal Semi-solids), and by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) PLUS Analysis of Leading Topical Drug Delivery Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Topical Drug Delivery Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Topical Drug Delivery Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category